US69404D1081
© Globe Newswire
28.11.2025
PACB
LISTED
NASDAQ
PacBio to Participate in the Piper Sandler 37th Annual Healthcare Conference
News Preview
MENLO PARK, Calif., Nov. 28, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participate in a fireside chat at Piper Sandler’s 37th Annual Healthcare Conference on Wednesday, December 3, 2025, at 11:30 AM ET in New York, NY....
Themefolio
Profiler
Peergroup
© Globe Newswire
05.11.2025
PACB
LISTED
NASDAQ
HiFi Solves Consortium Publishes First Major Study Demonstrating the Clinical Research Power of PacBio HiFi Genomes
News Preview
New multi-center study identifies 100% of clinically relevant variants in the study, including those not detected by short-read sequencing technologies, positioning HiFi as the bridge between research and clinical-grade genomics New multi-center study identifies 100% of clinically relevant variants in the study, including those not detected by shor...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.11.2025
PACB
LISTED
NASDAQ
PacBio Supports Berry Genomics in Achieving First Regulatory Approval for Clinical Long-Read Sequencing in China
News Preview
NMPA approval on the Sequel II CNDx system enables clinicians in China to harness PacBio HiFi sequencing for challenging conditions, with initial offering for thalassemia NMPA approval on the Sequel II CNDx system enables clinicians in China to harness PacBio HiFi sequencing for challenging conditions, with initial offering for thalassemia...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
22.10.2025
PACB
LISTED
NASDAQ
PacBio to Report Third Quarter 2025 Financial Results on November 5, 2025
News Preview
MENLO PARK, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its third quarter 2025 financial results on Wednesday, November 5, 2025, at 4:30 pm Eastern Time....
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
14.10.2025
PACB
LISTED
NASDAQ
PacBio Announces Major Advances for Revio and Vega to Lower Genome Cost and Expand Multiomic Capabilities
News Preview
New SPRQ-Nx chemistry designed to deliver the most complete view of the genome for less than $300 at scale New SPRQ-Nx chemistry designed to deliver the most complete view of the genome for less than $300 at scale...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.10.2025
PACB
LISTED
NASDAQ
PacBio HiFi Technology Selected as Core Platform for South Korea’s National Pangenome Project
News Preview
More than 1,000 Korean genomes to be sequenced for global reference standards, advancing disease research and precision medicine More than 1,000 Korean genomes to be sequenced for global reference standards, advancing disease research and precision medicine...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.10.2025
PACB
LISTED
NASDAQ
Long Life Family Study Taps PacBio HiFi Sequencing to Unlock Genetic and Epigenetic Clues to Exceptional Longevity
News Preview
Up to 7,800 whole genomes and epigenomes to be sequenced on PacBio’s Revio system, powering one of the largest studies of healthy aging to date Up to 7,800 whole genomes and epigenomes to be sequenced on PacBio’s Revio system, powering one of the largest studies of healthy aging to date...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.10.2025
PACB
LISTED
NASDAQ
PacBio Expands Partnership with seqWell to Bring Scalable Long Read Sample Prep to More Labs
News Preview
Highly scalable, cost-effective LongPlex™ kit delivers streamlined tagmentation and multiplexing for low-pass whole genome sequencing, plasmid resequencing, and microbial sequencing Highly scalable, cost-effective LongPlex™ kit delivers streamlined tagmentation and multiplexing for low-pass whole genome sequencing, plasmid resequencing, and microbi...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.09.2025
PACB
LISTED
NASDAQ
PacBio Enters High-Throughput Carrier Screening Market with Standalone HiFi Sequencing Assay for Challenging Genes
News Preview
Enhanced PureTarget portfolio replaces the need for multiple tests with single scalable solution for inherited disease screening Enhanced PureTarget portfolio replaces the need for multiple tests with single scalable solution for inherited disease screening...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.09.2025
PACB
LISTED
NASDAQ
PacBio and EpiCypher Partner to Deliver Novel Insights into Epigenomics with Fiber-seq Workflow
News Preview
New addition to PacBio Compatible program enables scientists to connect genetic variation with gene regulation in a single assay, advancing research in rare disease and cancer New addition to PacBio Compatible program enables scientists to connect genetic variation with gene regulation in a single assay, advancing research in rare disease and cance...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.07.2025
PACB
LISTED
NASDAQ
PacBio HiFi Sequencing Powers First Arab Human Pangenome, Published in Nature Communications
News Preview
Study reveals millions of previously unknown variants and genomic sequences from underrepresented populations Study reveals millions of previously unknown variants and genomic sequences from underrepresented populations...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.07.2025
PACB
LISTED
NASDAQ
PacBio Joins the 1000 Genomes Long Read Project to Add Isoform Sequencing with Kinnex and Revio
News Preview
New Iso-Seq data from ~1,000 samples to expand transcriptomic insights using highly accurate HiFi sequencing New Iso-Seq data from ~1,000 samples to expand transcriptomic insights using highly accurate HiFi sequencing...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
02.06.2025
PACB
LISTED
NASDAQ
Target ALS Chooses PacBio HiFi Sequencing to Advance ALS Research with Largest Global Genomic Study to Date
News Preview
Organization's 6,000-genome effort will power global ALS research through detailed long-read sequencing data made freely available to scientists worldwide
NEW YORK and MENLO PARK, Calif., June 2, 2025 /PRNewswire/ -- Target ALS, a nonprofit breaking down barriers to amyotrophic lateral sclerosis (ALS) research, has partnered with PacBio (Nasdaq:...
Themefolio
Profiler
Peergroup
© Globe Newswire
12.05.2025
PACB
LISTED
NASDAQ
PacBio Board Independent Investigation Concludes Allegations Unsubstantiated
News Preview
MENLO PARK, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced that the Special Committee of its Board of Directors (the “Special Committee”) has concluded its independent investigation into previously disclosed allegations from an attorney representing an employee impacted by our recent reduction in force regarding ce...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.05.2025
PACB
LISTED
NASDAQ
PacBio Announces First Quarter 2025 Financial Results
News Preview
MENLO PARK, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
05.05.2025
PACB
LISTED
NASDAQ
First Effort to Integrate PacBio HiFi Whole Genome Sequencing in Newborn Screening Launches in Thailand
News Preview
Collaboration leverages HiFi’s unique ability to reveal hidden variants, bringing a new level of precision to early life genetic screening Collaboration leverages HiFi’s unique ability to reveal hidden variants, bringing a new level of precision to early life genetic screening...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.04.2025
PACB
LISTED
NASDAQ
PacBio Announces Plans to Improve Methylation Detection in HiFi Chemistry
News Preview
Company licenses novel deep learning-based epigenetic models from CUHK enabling the detection of 5hmC, 5mC hemimethylation, and 6mA in standard sequencing runs Company licenses novel deep learning-based epigenetic models from CUHK enabling the detection of 5hmC, 5mC hemimethylation, and 6mA in standard sequencing runs...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.04.2025
PACB
LISTED
NASDAQ
Davos Alzheimer’s Collaborative Selects PacBio as Technology Partner for Global Project to Advance Alzheimer’s Disease Research in North Africa
News Preview
International research team aims to develop better understanding of Alzheimer’s disease and dementia in diverse populations International research team aims to develop better understanding of Alzheimer’s disease and dementia in diverse populations...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.04.2025
PACB
LISTED
NASDAQ
PacBio Announces Preliminary First Quarter 2025 Revenue and Reiterates 2025 Revenue Guidance of $155 Million to $170 Million
News Preview
Implements Plan to Reduce Annualized Operating Expense Run Rate by $45 Million to $50 Million...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.04.2025
PACB
LISTED
NASDAQ
PacBio Grants Equity Incentive Award to New Employee
News Preview
MENLO PARK, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee of the Company’s Board of Directors granted a non-qualified stock option (the “Option”) covering 342,432 shares of PacBio common stock to the Compan...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.03.2025
PACB
LISTED
NASDAQ
Jim Gibson to join PacBio as Chief Financial Officer
News Preview
MENLO PARK, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced Jim Gibson will join and be appointed as the company’s new Chief Financial Officer, effective as of his start date, which is expected to be March 31, 2025. With over three decades...
Themefolio
Profiler
Peergroup
© Globe Newswire
17.03.2025
PACB
LISTED
NASDAQ
Scientists Solve One of Genomics’ Biggest Challenges by Using HiFi Sequencing to Distinguish Highly Similar Paralogous Genes
News Preview
MENLO PARK, Calif., March 17, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced a newly published study in Nature Communications unveiling a powerful new method for analyzing some of the most complex regions of the human genome. Led by researchers from PacBio,...
Themefolio
Profiler
Peergroup
© Globe Newswire
15.02.2025
PACB
LISTED
NASDAQ
PacBio Grants Equity Incentive Award to New Employee
News Preview
MENLO PARK, Calif., Feb. 14, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee of the Company’s Board of Directors granted a non-qualified stock option (the “Option”) covering 400,000 shares of PacBio common stock, and restricte...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.02.2025
PACB
LISTED
NASDAQ
PacBio Announces Fourth Quarter and Fiscal Year 2024 Financial Results
News Preview
MENLO PARK, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter and fiscal year ended December 31, 2024....
Themefolio
Profiler
Peergroup
© Globe Newswire
03.02.2025
PACB
LISTED
NASDAQ
PacBio Announces Appointment of David Ruggiero as Head of Global Sales & Service
News Preview
MENLO PARK, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the appointment of David Ruggiero as the company’s new Global Head of Sales & Service....
Themefolio
Profiler
Peergroup
© Globe Newswire
30.01.2025
PACB
LISTED
NASDAQ
PacBio Announces Appointment of Chris Smith to Board of Directors
News Preview
PacBio to leverage Chris' extensive expertise in diagnostics and laboratory testing markets, as Board Member David Meline steps down. PacBio to leverage Chris' extensive expertise in diagnostics and laboratory testing markets, as Board Member David Meline steps down....
Themefolio
Profiler
Peergroup
© Globe Newswire
29.01.2025
PACB
LISTED
NASDAQ
PacBio Technology Powers Landmark Multiomic Study Published in Nature Genetics
News Preview
New sequencing approach resolves the genetic complexity of a rare Mendelian condition New sequencing approach resolves the genetic complexity of a rare Mendelian condition...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.01.2025
PACB
LISTED
NASDAQ
PacBio Names Global Institute for Food Security as Canada's First Revio Certified Service Provider
News Preview
MENLO PARK, Calif., Jan. 23, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the Global Institute for Food Security (GIFS) at the University of Saskatchewan (USask) as the first Revio PacBio Certified Service Provider (CSP) in Canada....
Themefolio
Profiler
Peergroup
© Globe Newswire
14.01.2025
PACB
LISTED
NASDAQ
PacBio and Radboud UMC Announce Remarkable Study Results Using HiFi Long Read Sequencing to Help Advance Rare Disease Diagnostics
News Preview
MENLO PARK, Calif., Jan. 14, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of highly accurate long-read sequencing solutions, announced a significant publication from Radboud University Medical Center (Radboudumc) and its research partners in the American Journal of Human Genetics. The study demonstrates the impact of PacBio’...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.01.2025
PACB
LISTED
NASDAQ
PacBio Announces Preliminary Fourth Quarter and Full Year Revenue
News Preview
Commenced shipment of the Vega™ benchtop system ahead of schedule, bringing HiFi sequencing to more customers...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.01.2025
PACB
LISTED
NASDAQ
PacBio and Intus Bio Collaborate for Launch of GutID, First At-Home Microbiome Test Powered by HiFi Sequencing
News Preview
MENLO PARK, Calif., Jan. 10, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, and Intus Bio, a leader in microbiome research and discovery, today unveiled GutID, the first commercial human gut health test powered by Intus Bio’s groundbreaking Titan-1 platform and PacBio’s HiFi sequenc...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.01.2025
PACB
LISTED
NASDAQ
PacBio Announces Shipment of Vega Systems to Berry Genomics to Support its Clinical Assay Development for Asian Markets
News Preview
Berry Genomics will leverage PacBio Vega System to develop long-read sequencing-based solutions for patients in China and other countries Berry Genomics will leverage PacBio Vega System to develop long-read sequencing-based solutions for patients in China and other countries...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.11.2024
PACB
LISTED
NASDAQ
PacBio to Present at Upcoming Investor Conferences
News Preview
MENLO PARK, Calif., Nov. 08, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be participating in the following upcoming investor conferences:...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.11.2024
PACB
LISTED
NASDAQ
PacBio Unveils the Vega System, a New Sequencing Platform Bringing HiFi to the Benchtop
News Preview
Priced at just $169,000 Vega is designed to make highly accurate long-read sequencing accessible to any laboratory Priced at just $169,000 Vega is designed to make highly accurate long-read sequencing accessible to any laboratory...
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2024
PACB
LISTED
NASDAQ
Volta Labs joins PacBio Compatible program to help PacBio customers scale sequencing through automated library prep
News Preview
BOSTON, Oct. 30, 2024 /PRNewswire/ -- Volta Labs™, a genomics applications company, announced today that it has joined the PacBio Compatible program, further expanding the partnership between Volta Labs and PacBio.
Volta Labs is pa...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2024
PACB
LISTED
NASDAQ
PacBio Announces SPRQ Chemistry for Revio Sequencing Systems, a Major Advance Reducing the Cost of a HiFi Human Genome to less than $500
News Preview
New long-read sequencing chemistry reduces DNA input requirements four-fold, enables a 33% increase in data output per SMRT Cell, improves methylation calling, and expands support for multiomics New long-read sequencing chemistry reduces DNA input requirements four-fold, enables a 33% increase in data output per SMRT Cell, improves methylation call...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.10.2024
PACB
LISTED
NASDAQ
PacBio Onso™ Short Read Sequencing Instrument Joins 10x Genomics Compatible Partner Program
News Preview
MENLO PARK, Calif., Oct. 22, 2024 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate genomic sequencing solutions, today announced the inclusion of the Onso short-read sequencing platform in the 10x Genomics Compatible Partner Program. The 10x Genomics Compatible Partner Program recognizes instruments...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.10.2024
PACB
LISTED
NASDAQ
PacBio Enters Cancer Genomics Research Collaboration in Singapore with Advanced Onso Sequencing
News Preview
Groundbreaking collaboration to unlock the full potential of PacBio’s Onso technology, accelerating breakthroughs in cancer genomics across Asia Groundbreaking collaboration to unlock the full potential of PacBio’s Onso technology, accelerating breakthroughs in cancer genomics across Asia...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.10.2024
PACB
LISTED
NASDAQ
PacBio to Report Third Quarter 2024 Financial Results on November 7, 2024
News Preview
MENLO PARK, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its third quarter 2024 financial results on Thursday, November 7, 2024, at 4:30 pm Eastern Time....
Themefolio
Profiler
Peergroup
© Globe Newswire
01.10.2024
PACB
LISTED
NASDAQ
PacBio, A*STAR, and Macrogen Unveil State-of-the-Art Lab to Accelerate Genomics Innovation in Singapore
News Preview
The new lab will leverage PacBio’s HiFi sequencing technology to broaden access to highly accurate long-read sequencing and multi-omics solutions in Southeast Asia The new lab will leverage PacBio’s HiFi sequencing technology to broaden access to highly accurate long-read sequencing and multi-omics solutions in Southeast Asia...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.09.2024
PACB
LISTED
NASDAQ
PacBio Grants Equity Incentive Award to New Employee
News Preview
MENLO PARK, Calif., Sept. 27, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee of the Company’s Board of Directors granted a non-qualified stock option (the “Option”) covering 100,000 shares of PacBio common stock, and restrict...
Themefolio
Profiler
Peergroup
© Globe Newswire
11.09.2024
PACB
LISTED
NASDAQ
PacBio Announces the HiFi Solves Sub-fertility Consortium in Asia Pacific
News Preview
Collaboration Aims to Harness HiFi Sequencing to Improve Diagnosis and Treatment of Subfertility and Recurrent Pregnancy Loss Collaboration Aims to Harness HiFi Sequencing to Improve Diagnosis and Treatment of Subfertility and Recurrent Pregnancy Loss...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.09.2024
PACB
LISTED
NASDAQ
Revio to Power Research in Male Infertility and Rare Disease at Münster University Hospital
News Preview
Highly Accurate Long-Read Sequencing Data from Revio will Support Germany’s National Genome Initiative and Provide Data to the International Male Infertility Consortium Highly Accurate Long-Read Sequencing Data from Revio will Support Germany’s National Genome Initiative and Provide Data to the International Male Infertility Consortium...
Themefolio
Profiler
Peergroup
© Globe Newswire
23.07.2024
PACB
LISTED
NASDAQ
Novogene to Power Cancer, Rare Disease, and Environmental Research with PacBio Sequencing
News Preview
Highly accurate long-read sequencing data will be used at Novogene’s new lab in Munich, supporting customers across a network of leading research institutions Highly accurate long-read sequencing data will be used at Novogene’s new lab in Munich, supporting customers across a network of leading research institutions...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
